February 5, 2025 - 07:31
The Centers for Disease Control and Prevention (CDC) has not issued its weekly Morbidity and Mortality Weekly Report (MMWR) since January 16, raising concerns about the flow of vital public health information. This prolonged silence has left many stakeholders, including healthcare professionals and the general public, eager for updates on critical health data and trends.
While some communication barriers from federal health agencies have been eased, the majority of information remains restricted. The lack of regular updates from the CDC is particularly alarming as the nation continues to navigate ongoing public health challenges. Experts emphasize the importance of timely data dissemination to inform decision-making and enhance community preparedness.
As discussions about transparency and accountability in federal health communication continue, the public awaits a resumption of regular reporting. Maintaining open lines of communication is crucial for fostering trust and ensuring that communities are equipped with the information they need to stay safe and healthy.
June 7, 2025 - 05:44
California Lawmakers Explore Tax on Major Corporations to Fund HealthcareCalifornia Democratic lawmakers are in discussions to introduce a new tax targeting large corporations, including Amazon and Walmart, aimed at alleviating the state`s healthcare costs. This...
June 6, 2025 - 18:04
Omada Health Makes Its Nasdaq Debut with Strong Opening PriceOmada Health became the latest tech company to hit the Nasdaq on Friday, as the IPO market picks up steam. The digital health company opened its shares at $23, signaling a positive reception from...
June 6, 2025 - 01:39
Self-Administered Health Tests: A Guide to Choosing the Right One for YouIn recent years, the availability of self-administered health tests has significantly increased, allowing individuals to monitor their health from the comfort of their homes. These tests cover a...
June 5, 2025 - 02:33
Medicare Drug Price Negotiations Progress Amid Ongoing EffortsIn the shadow of President Trump`s efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues to gain momentum. The initiative aims...